Emerging targets of α-synuclein spreading in α-synucleinopathies: a review of mechanistic pathways and interventions
Abstract α-Synucleinopathies constitute a spectrum of neurodegenerative disorders, including Parkinson’s disease (PD), Lewy body dementia (LBD), Multiple System Atrophy (MSA), and Alzheimer’s disease concurrent with LBD (AD-LBD). These disorders are unified by a pathological hallmark: aberrant misfo...
Saved in:
Main Authors: | Grace Kuo, Ramhari Kumbhar, William Blair, Valina L. Dawson, Ted M. Dawson, Xiaobo Mao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Molecular Neurodegeneration |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13024-025-00797-1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Novel Poly-Arginine Peptide R18D Reduces α-Synuclein Aggregation and Uptake of α-Synuclein Seeds in Cortical Neurons
by: Emma C. Robinson, et al.
Published: (2025-01-01) -
USP14 is crucial for proteostasis regulation and α-synuclein degradation in human SH-SY5Y dopaminergic cells
by: Vignesh Srinivasan, et al.
Published: (2025-02-01) -
Refining α-synuclein seed amplification assays to distinguish Parkinson’s disease from multiple system atrophy
by: James A. Wiseman, et al.
Published: (2025-02-01) -
β-synuclein in cerebrospinal fluid as a potential biomarker for distinguishing human prion diseases from Alzheimer’s and Parkinson’s disease
by: Bing Xu, et al.
Published: (2025-02-01) -
The effect of AKT inhibition in α-synuclein-dependent neurodegeneration
by: Bedri Ranxhi, et al.
Published: (2025-02-01)